Insomnia News and Research

Latest Insomnia News and Research

Regular exercise can lessen back pain and insomnia for pregnant women

It may not be enough for women to spend just 30 minutes a day on a treadmill or elliptical if they want to manage their weight during pregnancy. Regular exercise can help lessen back pain, increase energy levels and reduce insomnia for pregnant women.

20 Aug 2013

Hitting treadmill today won't help you sleep tonight; it takes 4 months to kick in

Exercise is a common prescription for insomnia. But spending 45 minutes on the treadmill one day won't translate into better sleep that night, according to new Northwestern Medicine- research.

16 Aug 2013

Cultural mythologies strongly influence women’s expectations during pregnancy

Morning sickness, shiny hair and bizarre and intense cravings for pickles and ice cream -- what expectations do pregnant women impose on their bodies, and how are those expectations influenced by cultural perspectives on pregnancy? University of Cincinnati researcher Danielle Bessett, an assistant professor of sociology, presented her research at the 108th annual meeting of the American Sociological Association in New York, N.Y.

14 Aug 2013

FDA: New drug Tivicay approved to treat HIV-1 infection

The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary for HIV to multiply.

13 Aug 2013

Health benefits of sufficient sleep: an interview with Dr Monique Verschuren, National Institute for Public Health and the Environment, the Netherlands

We used 6 hours or less per 24 hours as the definition of insufficient sleep, with 7 hours or more as sufficient sleep. In general, this is considered the amount of sleep that is sufficient for adults, although there can be differences between persons with respect to the amount of sleep needed.

6 Aug 2013

Exercise can improve overall health but does not reduce hot flashes in midlife women

Exercise has proven health benefits, but easing hot flashes isn't one of them. After participating in a 12-week aerobic exercise program, sedentary women with frequent hot flashes had no fewer or less bothersome hot flashes than a control group.

31 Jul 2013

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy

26 Jul 2013

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

26 Jul 2013

Scientists take important step toward pharmacologic development of treatment for fatal brain disorders

A team of researchers from Case Western Reserve University School of Medicine have identified a mechanism that can prevent the normal prion protein from changing its molecular shape into the abnormal form responsible for neurodegenerative diseases. This finding, published in the July 18 issue of Cell Reports, offers new hope in the battle against a foe that until now has always proved fatal.

19 Jul 2013

Poor sleep during pregnancy can disrupt immune processes and lead to lower birth weights

Poor sleep quality and quantity during pregnancy can disrupt normal immune processes and lead to lower birth weights and other complications, finds a University of Pittsburgh School of Medicine study published today in the journal Psychosomatic Medicine. Women with depression also are more likely than non-depressed women to suffer from disturbed sleep and to experience immune system disruption and adverse pregnancy outcomes.

18 Jul 2013

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully-integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that, through a wholly-owned subsidiary, the company entered into an agreement to acquire Talon Therapeutics, Inc., a biopharmaceutical company based in South San Francisco, California, and expects to complete the acquisition within one day.

17 Jul 2013

Drexel University receives NIH grant to study medical marijuana use among LA young adults

Drexel University has received a grant for a five-year study of medical marijuana and its impact on drug use and physical and psychological health among young adults in Los Angeles. It is the first large-scale NIH project funded to directly investigate medical marijuana use among young adults aged 18 to 26.

15 Jul 2013

Study examines whether better sleep lowers risk of heart disease

The University of South Florida College of Nursing is conducting research to improve sleep in those caring for people with dementia and Alzheimer's disease, with the aim of determining if better sleep affects heart health.

10 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

FDA sends Complete Response Letter to Merck regarding investigational drug for insomnia

Merck, known as MSD outside the United States and Canada, announced today that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application for suvorexant, Merck's investigational medicine for the treatment of insomnia.

2 Jul 2013

Pre-deployment insomnia symptoms associated with major mental disorders

A new study from the Perelman School of Medicine at the University of Pennsylvania and the Naval Health Research Center has shown Military service members who have trouble sleeping prior to deployments may be at greater risk of developing posttraumatic stress disorder (PTSD), depression and anxiety once they return home.

30 Jun 2013

Study shows that individuals with SAD misreport sleep patterns due to depression

Lying awake in bed plagues everyone occasionally, but for those with seasonal affective disorder, sleeplessness is routine. University of Pittsburgh researchers report in the Journal of Affective Disorders that individuals with seasonal affective disorder -a winter depression that leads to loss of motivation and interest in daily activities-have misconceptions about their sleep habits similar to those of insomniacs.

28 Jun 2013

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

The US Food and Drug Administration has expanded the approved indication for Exelon Patch (rivastigmine transdermal system) to include the treatment of people with severe Alzheimer's disease with Exelon Patch 13.3mg/24h.

28 Jun 2013

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.

24 Jun 2013

Research: Sleep mechanism enables brain to consolidate emotional memory

Sleep researchers from University of California campuses in Riverside and San Diego have identified the sleep mechanism that enables the brain to consolidate emotional memory and found that a popular prescription sleep aid heightens the recollection of and response to negative memories.

13 Jun 2013

Insomnia News and Research

Latest Insomnia News and Research

Regular exercise can lessen back pain and insomnia for pregnant women

Hitting treadmill today won't help you sleep tonight; it takes 4 months to kick in

Cultural mythologies strongly influence women’s expectations during pregnancy

FDA: New drug Tivicay approved to treat HIV-1 infection

Health benefits of sufficient sleep: an interview with Dr Monique Verschuren, National Institute for Public Health and the Environment, the Netherlands

Exercise can improve overall health but does not reduce hot flashes in midlife women

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Scientists take important step toward pharmacologic development of treatment for fatal brain disorders

Poor sleep during pregnancy can disrupt immune processes and lead to lower birth weights

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Drexel University receives NIH grant to study medical marijuana use among LA young adults

Study examines whether better sleep lowers risk of heart disease

Soligenix announces personalized medicine collaboration with SciClone

FDA sends Complete Response Letter to Merck regarding investigational drug for insomnia

Pre-deployment insomnia symptoms associated with major mental disorders

Study shows that individuals with SAD misreport sleep patterns due to depression

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

EC grants marketing authorization for XTANDI capsules for treating advanced prostate cancer

Research: Sleep mechanism enables brain to consolidate emotional memory

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Insomnia News and Research

Latest Insomnia News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in